IDH2 and acute myeloid leukemia: We performed similar experiments in FOXC1high primary human AML cells from a patient with normal karyotype AML with mutations in NPM1, FLT3, DNMT3A, and IDH2 (BB475; Table S1), with similar results (Figures 1F–1I and S1F–S1H).